Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain

Nature Chemistry

Volumn 3, Issue 6, 2011, Pages 449-453

  Tarselli, Michael A ^a   Raehal, Kirsten M ^a   Brasher, Alex K ^a   Streicher, John M ^a   Groer, Chad E ^a   Cameron, Michael D ^a   Bohn, Laura M ^a   Micalizio, Glenn C ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONOLIDINE; INDOLE ALKALOID; NARCOTIC ANALGESIC AGENT;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; INTRACTABLE PAIN; MALE; MOUSE; SYNTHESIS; TABERNAEMONTANA;

ANALGESICS, OPIOID; ANIMALS; DISEASE MODELS, ANIMAL; INDOLE ALKALOIDS; MALE; MICE; MICE, INBRED C57BL; PAIN, INTRACTABLE; TABERNAEMONTANA;

EID: 79957449204     PISSN: 17554330     EISSN: 17554349     Source Type: Journal    
DOI: 10.1038/nchem.1050     Document Type: Article

References (34)

1. Melnikova, I. The pain market. Nat. Rev. Drug Discov. 9, 589-590 (2010).
2. Crofford, L. J. Adverse effects of chronic opioid therapy for chronic musculoskeletal pain. Nat. Rev. Rheum. 6, 191-197 (2010).
3. Kam, T.-S., Pand, H.-S., Choo, Y.-M. & Komiyama, K. Biologically active ibogan and vallesamine derivatives from Tabernaemontana divaricata. Chem. Biodivers. 1, 646-656 (2004).
4. Pratchayasakul, W., Pongchaidecha, A., Chattipakorn, N. & Chattipakorn, S. Ethnobotany & ethnopharmacology of Tabernaemontana divaricata. Indian J. Med. Res. 127, 317-335 (2008).
5. Ingkaninan, K., Ijzerman, A. P., Taesotikul, T. & Verpoorte, R. Isolation of opioid-active compounds from Tabernaemopntana pachysiphon leaves. J. Pharm. Pharmacol. 51, 1441 (1999).
6. Scott, A. I., Yeh, C.-L. & Greenslade, D. Laboratory model for the biosynthesis of vallesamine, apparicine, and related alkaloids. J. Chem. Soc. Chem. Commun. 947-948 (1978).
7. Lim, D-H., Low, T-Y. & Kam, T-S. Biomimetic oxidative transformations of pericine: partial synthesis of apparicine and valparicine, a new pentacyclic indole alkaloid from Kopsia. Tetrahedron Lett. 47, 5037-5039 (2006). (Pubitemid 43867630)
8. Ahond, A., Cavé, A., Kan-Fan, C., Langlois, Y. & Potier, P. The fragmentation of N,N-dimethyltryptamine oxide and related compounds: a possible implication in indole alkaloid biosynthesis. J. Chem. Soc. Chem. Commun. 517 (1970).
9. Hoffmann, R. W. Allylic 1,3-strain as a controlling factor in stereoselective transformations. Chem. Rev. 89, 1841-1860 (1989).
10. Bennasar, M.-L., Zulaica, E., Solé, D., Roca, T., García-Díaz, D. & Alonso, S. Total synthesis of the bridged indole alkaloid apparicine. J. Org. Chem. 74, 8359-8368 (2009).
11. Amat, M., Dolors Coll, M., Passarella, D. & Bosch, J. An enantioselective synthesis of the Strychnos alkaloid (2)-tubifoline. Tetrahedron: Asymmetry 7, 2775-2778 (1996). (Pubitemid 26343023)
12. Amat, M., Dolors Coll, M., Bosch, J., Espinosa, E. & Molins, E., Total syntheses of the Strychnos indole alkaloids (2)-tubifoline, (2)-tubifolidine, and (2)- 19,20-dihydroakuammicine. Tetrahedron: Asymmetry 8, 935-948 (1997). (Pubitemid 27136370)
13. Kolundzic, F. & Micalizio, G. C. Synthesis of substituted 1,4-dienes by direct alkylation of allylic alcohols. J. Am. Chem. Soc. 129, 15112-15113 (2007). (Pubitemid 350247781)
14. Still, W. C. & Mitra, A. A highly stereoselective synthesis of Z-trisubstituted olefins via [2,3]-sigmatropic rearrangement. Preference for a pseudoaxially substituted transition state. J. Am. Chem. Soc. 100, 1927-1928 (1978).
15. Hart, S. A., Trindle, C. O. & Etzkorn, F. A. Solvent-dependent stereoselectivity in a Still-Wittig rearrangement: an experimental and ab initio study. Org. Lett. 3, 1789-1791 (2001). (Pubitemid 33625212)
16. Wang, X. J., Hart, S. A., Xu, B., Mason, M. D., Goodell, F. R. & Etzkorn, F. A. Serine-cis-proline and serine-trans-proline isosteres: stereoselective synthesis of (Z)- and (E)-alkene mimics by Still-Wittig and Ireland-Claisen rearrangements. J. Org. Chem. 68, 2343-2349 (2003). (Pubitemid 36505115)
17. Fristad, W. E. & Paquette, L. A. Oxidation chemistry of a cis-2-(3- flurylidene)ethanol. Heterocycles 31, 2219-2224 (1990).
18. Le Bars, D., Gozariu, M. & Cadden, S. W. Animal models of nociception. Pharmacol. Rev. 53, 597-652 (2001). (Pubitemid 33136239)
19. Collier, H. O. J., Dinneedn L. C., Johnson, C. A. & Schneider, C. The abdominal constriction response and its suppression by analgesics in the mouse. Br. J. Pharmac. Chemother. 32, 295-310 (1968).
20. Mogil, J. S., Kest, B., Sadowski, B. & Belknap, J. K. Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay. J. Pharmacol. Exp. Ther. 276, 532-544 (1996).
21. Dubuisson, D. & Dennis, S. G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4, 161-174 (1977). (Pubitemid 8234766)
22. McNamara, C. R. et al. TRPA1 mediates formalin-induced pain. Proc. Natl Acad. Sci. USA 104, 13525-13530 (2007). (Pubitemid 47293978)
23. Woolf, C. J. Evidence for a central component of post-injury pain hypersensitivity. Nature 306, 686-688 (1983). (Pubitemid 14201852)
24. Tjølsen, A., Berge, O. G., Hunskaar, S., Rosland, J. H. & Hole, K. The formalin test: an evaluation of the method. Pain 51, 5-17 (1992).
25. Li, X., Kamenecka, T. M. & Cameron, M. D. Bioactivation of the epidermal growth factor receptor inhibitor gefitinib: implications for pulmonary and hepatic toxicities. Chem. Res. Toxicol. 22, 1736-1742 (2009).
26. Wess, J. et al. Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice: a review. Life Sci. 72, 2047-2054 (2003). (Pubitemid 36298946)
27. Stone, L. S., Fairbanks, C. A. & Wilcox, G. L. Moxonidine, a mixed alpha(2)- adrenergic and imidazoline receptor agonist, identifies a novel adrenergic target for spinal analgesia. Ann. NY Acad. Sci. 1009, 378-385 (2003). (Pubitemid 38265136)
28. Jann, M. W. & Slade, J. H. Antidepressant agents for the treatment of chronic pain and depression. Pharmacotherapy 27, 1571-1587 (2007). (Pubitemid 350060211)
29. Shimoyama, N., Shimoyama, M., Davis, A. M., Inturrisi, C. E. & Elliot, K. J. Spinal gabapentin is antinociceptive in the rat formalin test. Neurosci. Lett. 222, 65-67 (1997). (Pubitemid 27061093)
30. Hunter, J. C. et al. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. J. Pharmacol. 324, 153-160 (1997). (Pubitemid 27174600)
31. Munro, G. Pharmacological assessment of the rat formalin test utilizing the clinically used analgesic drugs gabapentin, lamotrigine, morphine, duloxetine, tramadol and ibuprofen: influence of low and high formalin concentrations. Eur. J. Pharmacol. 605, 95-102 (2009).
32. Baillie, J. K. & Power, I. The mechanism of action of gabapentin in neuropathic pain. Curr. Opin. Investig. Drugs 7, 33-39 (2006). (Pubitemid 43115778)
33. Goldstein, A. & Sheehan, P. Tolerance to opioid narcotics. I. Tolerance to the "running fit" caused by levorphanol in the mouse. J. Pharmacol. Exp. Ther. 169, 175-184 (1969).
34. Wise, R. A. & Bozarth, M. A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94, 469-492 (1987).